Blog Posts Discuss Use Of Bedaquiline To Treat Drug-Resistant TB In India, South Africa
The BMJ Opinion: Kanchan Mukherjee: Bedaquiline for multidrug resistant TB in India — at what cost?
Kanchan Mukherjee, a medical doctor and professor at the Tata Institute of Social Sciences in Mumbai, discusses the potential benefits and challenges of a wider government rollout of bedaquiline to treat multidrug-resistant TB in India (6/20).
IDSA’s “Science Speaks”: Advocates hail South Africa bedaquiline recommendation, replacing toxic injection for patients with drug-resistant tuberculosis
Antigone Barton, senior editor and writer of “Science Speaks,” highlights South Africa’s decision to begin using bedaquiline to treat patients with drug-resistant TB and advocates’ reactions to the policy change (6/20).